Clinical Trial: The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704645) titled 'The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer' on July 10.

Brief Summary: This study is an open-label, multicenter phase II clinical trial of adebelizumab combined with other anti-tumor therapies in patients with non-small cell lung cancer. The aim of this study was to evaluate the safety, tolerability and efficacy of adebelizumab combined with other anti-tumor therapies in patients with resectable non-small cell lung cancer ( NSCLC )

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Resectable Non-small Cell Lung Cancer

Interven...